Company Filing History:
Years Active: 2013
Title: Alastair J S Summerlee: Innovator in Cancer Treatment
Introduction
Alastair J S Summerlee is a notable inventor based in Guelph, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic agents.
Latest Patents
Summerlee holds a patent for "Modified H2 relaxin for tumor suppression." This invention involves modified H2 relaxins that act as antagonists of the relaxin receptor in cells and tissues. Specifically, these modified H2 relaxins include alterations in the amino acid sequence at positions B13, B17, and B20, which are located in the receptor binding domain. The antagonists maintain their affinity to the receptor but do not substantially activate it once bound. These H2 relaxin antagonists are utilized in compositions and methods for treating cancers where a relaxin receptor is expressed. He has 1 patent to his name.
Career Highlights
Summerlee's work has been instrumental in advancing cancer therapies. His research focuses on the development of innovative solutions that target specific receptors involved in tumor growth and progression. His dedication to improving patient outcomes through scientific discovery is commendable.
Collaborations
He has collaborated with notable colleagues, including Jeffrey A Medin and Joshua Daniel Silvertown, to further enhance the impact of his research in the field of oncology.
Conclusion
Alastair J S Summerlee's contributions to cancer treatment through his patented innovations highlight his role as a leading inventor in the medical field. His work continues to inspire advancements in therapeutic strategies for cancer patients.